PCI Biotech: Disclosure of voting rights for Chairman of the Board

Oslo, 24 May 2017. PCI Biotech Holding ASA ("PCI Biotech" or the "Company")
issue this notification on behalf of its chairman, Hans Peter  Bøhn.

Hans  Peter Bøhn is chairman of PCI Biotech and shall open the annual general
meeting of the Company on 29 May 2017. Mr. Bøhn holds 83,556 shares,
representing 0.3 per cent of the share capital of PCI  Biotech. By close of
business on 24 May 2017 Mr. Bøhn had received powers of attorney to represent
and vote for 5,540,502 additional shares. In total, Mr. Bøhn will represent and
vote for 22.6 per cent of the share capital. A major part of the powers of
attorney is without voting instructions. The powers of attorney are only valid
at the annual general meeting on 24 May 2017.

Contact information:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757


This information is subject to the disclosure requirements pursuant to section
5 -12 of the Norwegian Securities Trading Act.